Agile Therapeutics, Inc. announced the appointment of Dennis P. Reilly as Chief Financial Officer effective August 5, 2019. Mr. Reilly has had significant experience with commercial companies in the pharmaceutical and diagnostics sectors. Most recently, from 2017 to 2019, he served as Chief Financial and Operations Officer of Invisible Sentinel, Inc., a Philadelphia-based diagnostics company that was sold to BioMeriux.  From 2009 to 2017, Mr. Reilly was the Chief Financial Officer of NeoStrata Company, Inc. In 2017, and where he oversaw several important initiatives to restructure the company and return it to financial growth. Prior to that, from 2005 to 2008, he served as the Chief Financial Officer, and prior to that role as Controller, of Barrier Therapeutics, Inc.